Document:

Consulting Agreement

 Exhibit 10.83 
 CONSULTING AGREEMENT 
 Effective August 31, 2011 (“Effective
Date”), Frederic H. Moll, M.D., an individual (“Consultant”), and Hansen Medical, Inc., a Delaware corporation having a principal place of business at 800 E. Middlefield Road, Mountain View, CA 94043 (“Company”) agree as
follows: 
 Whereas, until the Effective Date of this Agreement, Consultant was an employee of Company and served as its
Executive Chairman; and 
 Whereas, Company and Consultant have agreed that Consultant will resign from, and terminate his
employment with, the Company on the Effective Date pursuant to the terms and conditions of a separation agreement (the “Separation Agreement”) and will transition immediately into a consulting role in accordance with the terms of this
Agreement; 
 Wherefore, Consultant and Company agree as follows: 

1. Services and Payment. Consultant agrees to undertake and complete the Services, and abide by the terms, set forth in Exhibit
A in accordance with and on the schedule specified in Exhibit A. As the only consideration due Consultant regarding the subject matter of this agreement (“Agreement”), Company will pay Consultant in accordance with Exhibit
A. 
 2. Ownership Rights; Proprietary Information; Publicity. 

a. Company shall own all right, title and interest (including patent rights, copyrights, trade secret rights, mask work rights, trademark
rights and all other intellectual and industrial property rights of any sort throughout the world) relating to any and all inventions (whether or not patentable), works of authorship, mask works, designations, designs, know-how, ideas and
information made or conceived or reduced to practice, in whole or in part, by Consultant during the term of this Agreement that relate to the subject matter of, or arise out of, the Services or any Proprietary Information (as defined below)
(collectively, “Inventions”) and Consultant will promptly disclose and provide all Inventions to Company. Consultant hereby makes all assignments necessary to accomplish the foregoing ownership. Consultant shall further assist Company, at
Company’s expense, to further evidence, record and perfect such assignments, and to perfect, obtain, maintain, enforce, and defend any rights assigned. Consultant hereby irrevocably designates and appoints Company as its agents and
attorneys-in-fact, coupled with an interest, to act for and on Consultant’s behalf to execute and file any document and to do all other lawfully permitted acts to further the foregoing with the same legal force and effect as if executed by
Consultant. 

 b. Consultant agrees that all Inventions and all other business, technical and financial
information (including, without limitation, the identity of and information relating to customers or employees) Consultant develops, learns or obtains in connection with Services or that are received by or for Company in confidence, constitute
“Proprietary Information.” Consultant will hold in confidence and not disclose or, except in performing the Services, use any Proprietary Information. However, Consultant shall not be obligated under this paragraph with respect to
information Consultant can document is or becomes readily publicly available without restriction through no fault of Consultant. Upon termination and as otherwise requested by Company, Consultant will promptly return to Company all items and copies
containing or embodying Proprietary Information, except that Consultant may keep its personal copies of its compensation records and this Agreement. Consultant also recognizes and agrees that Consultant has no expectation of privacy with respect to
Company’s telecommunications, networking or information processing systems (including, without limitation, stored computer files, email messages and voice messages) and that Consultant’s activity, and any files or messages, on or using any
of those systems may be monitored at any time without notice. 
 c. As additional protection for Proprietary Information,
Consultant agrees that (i) until one year after the Effective Date of this Agreement, Consultant will not directly solicit any employee or consultant of Company to leave Company for any reason, and (ii) during the period that he is
providing Services to the Company, (A) Consultant shall not engage in any activity with any organization in the field of robotically controlled flexible catheters for Electrophysiology or Vascular medical procedures and Consultant will not
assist any other person or organization in competing or in preparing to compete in the field of robotically controlled flexible catheters for Electrophysiology or Vascular medical procedures and (B) Consultant will not accept employment
with or directly or indirectly provide any type of services for Intuitive Surgical, Inc., Corindus Inc., or Catheter Robotics, Inc. to the extent such employment or services would compete with Hansen’s present or anticipated business.
Consultant will notify Company within five (5) business days if and when Consultant accepts full time employment, and shall provide the identity of the full-time employer and the time employment with that company commenced. 

d. To the extent allowed by law, Section 2.a and any license to Company hereunder includes all rights of paternity, integrity,
disclosure and withdrawal and any other rights that may be known as or referred to as “moral rights,” “artist’s rights,” “droit moral,” or the like. To the extent any of the foregoing is ineffective under
applicable law, Consultant hereby provides any and all ratifications and consents necessary to accomplish the purposes of the foregoing to the extent possible. Consultant will confirm any such ratifications and consents from time to time as
requested by Company. If any other person provides any Services, Consultant will obtain the foregoing ratifications, consents and authorizations from such person for Company’s exclusive benefit. 

e. If any part of the Services or Inventions is based on, incorporates, or is an improvement or derivative of, or cannot be reasonably
and fully made, used, reproduced, distributed and otherwise exploited without using or violating technology or intellectual property rights owned or licensed by Consultant and not assigned hereunder, Consultant hereby grants Company and its
successors a perpetual, irrevocable, worldwide royalty-free, non-exclusive, sublicensable right and license to exploit and exercise all such technology and intellectual property rights in support of Company’s exercise or exploitation of the
Services, Inventions, other work performed hereunder, or any assigned rights (including any modifications, improvements and derivatives of any of them). 

  
 2 

 3. Warranty. Consultant warrants that: (i) the Services will be performed in a
professional and workmanlike manner and that none of such Services nor any part of this Agreement is or will be inconsistent with any obligation Consultant may have to others; (ii) all work under this Agreement shall be Consultant’s
original work and none of the Services or Inventions or any development, use, production, distribution or exploitation thereof will infringe, misappropriate or violate any intellectual property or other right of any person or entity (including,
without limitation, Consultant); and, (iii) Consultant has the full right to allow it to provide the Company with the assignments and rights provided for herein. 
 4. Former or Conflicting Obligations. Consultant represents and warrants to the Company that Consultant will not disclose to the Company, or use, or induce the Company to use, any proprietary
information or trade secrets of others. Consultant represents that Consultant’s performance of services under this Agreement will not breach any agreement not to compete with others or any agreement to keep in confidence proprietary information
acquired by Consultant in confidence or in trust prior to the effective date of this Agreement. Consultant certifies that Consultant has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that
would preclude Consultant from complying with the provisions hereof. 
 5. Termination. 

a. This Agreement will automatically terminate on the last day of the term specified on Exhibit A. Prior to such date, either party may
terminate this Agreement with or without cause upon notice to the other party. Upon termination, the Company shall pay Consultant all unpaid, undisputed amounts due for the Services completed prior to such termination within ten (10) business
days of the date of termination. 
 b. Sections 2 (subject to the limitations set forth in Section 2.c) through 9 of this
Agreement and any remedies for breach of this Agreement shall survive any termination or expiration. Company may communicate such obligations to any other (or potential) client or employer of Consultant. 

6. Independent Contractor; No Employee Benefits. Consultant under this Agreement is an independent contractor (not an employee or
other agent) solely responsible for the manner and hours in which Services are performed, is solely responsible for all taxes, withholdings, and other statutory, regulatory or contractual obligations of any sort (including, but not limited to, those
relating to workers’ compensation, disability insurance, Social Security, unemployment compensation coverage, the Fair Labor Standards Act, income taxes, etc.), and is not entitled to any to participate in any employee benefit plans, fringe
benefit programs, group insurance arrangements or similar programs, subject to the exceptions explicitly set forth in Exhibit A. . 
 7. Assignment. This Agreement and the services contemplated hereunder are personal to Consultant and Consultant shall not have the right or ability to assign, transfer, or subcontract any
obligations under this Agreement without the written consent of Company. Any attempt to do so shall be void. Company may assign its rights and obligations under this agreement in whole or part to any successor to all or substantially all of the
business and/or assets of the Company. 

  
 3 

 8. Notice. All notices under this Agreement shall be in writing, and shall be deemed
given when personally delivered, or three days after being sent by prepaid certified or registered U.S. mail to the address of the party to be noticed as set forth herein or such other address as such party last provided to the other by written
notice, or if sent by email, but only upon receipt of the email being acknowledged by the recipient. 
  

			
	If to Consultant:	  	The contact information appears below Consultant’s signature block.
		
	If to Company:	  	Hansen Medical, Inc.
		  	 800 E. Middlefield Road

Mountain View, CA 94043

		  	Attn: Chief Executive Officer
		  	Tel: (650) 404-5800

 9. Miscellaneous. Any breach of Section 2 or 3 will cause irreparable harm to Company for
which damages would not be an adequate remedy, and therefore, Company will be entitled to injunctive relief with respect thereto in addition to any other remedies. The failure of either party to enforce its rights under this Agreement at any time
for any period shall not be construed as a waiver of such rights. This Agreement constitutes the entire agreement between you and the Company regarding the subject matter of this Agreement and renders null and void all prior and contemporaneous
written or oral agreements between you and the Company regarding the subject matter of this Agreement. No changes or modifications or waivers to this Agreement will be effective unless in writing and signed by both parties. In the event that any
provision of this Agreement shall be determined to be illegal or unenforceable, that provision will be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain in full force and effect and enforceable. This
Agreement shall be governed by and construed in accordance with the laws of the State of California without regard to the conflicts of laws provisions thereof. Headings herein are for convenience of reference only and shall in no way affect
interpretation of the Agreement. This Agreement may be executed in counterparts, each of which will be considered an original, but all of which together will constitute one agreement. Execution of a facsimile copy will have the same force and effect
as execution of an original, and a facsimile signature will be deemed an original and valid signature. 
  

  
 4 

							
	CONSULTANT	 		 	HANSEN MEDICAL, INC.
				
	 /S/ FREDERIC H. MOLL, M.D.
	 		 	By	 	 /S/ BRUCE J BARCLAY

	Dr. Frederic H. Moll, M.D	 		 		 	Bruce J Barclay
		 		 		 	President & Chief Executive Officer
				
	Address:	 		 		 	
				
	  
	 		 		 	
				
	  
	 		 		 	

  

  
 5 

 EXHIBIT A 

 

	1.	Term: Up to twelve (12) months from the Effective Date. 

  

	2.	Reporting to the Chief Executive Officer (the “CEO”). 

  

	3.	For the period beginning on the Effective Date through February 29, 2012, the only consideration due Consultant for the Services (as defined below) shall be
vesting of the 87,500 restricted stock units granted to Consultant on December 20, 2010, as described in this Paragraph 3. On March 1, 2012, any unvested December 20, 2010 RSUs will fully vest, provided that this Agreement has not
been terminated and Consultant has performed the Services requested by the Company’s CEO through such date. Notwithstanding the foregoing, if the Company terminates this Agreement prior to March 1, 2012 for any reason other than
Consultant’s material breach of this Agreement or in the event of Consultant’s death prior to such date, then the December 20, 2010 RSUs will fully vest on the date this Agreement is terminated by the Company or on the date of
Consultant’s death, as applicable. In this regard, the inability of Consultant to perform the Services as a result of his medically determinable physical or mental illness that is expected to result in death or which otherwise renders
Consultant incapable of performing requested Services shall not constitute a material breach of this Agreement. 

  

	4.	Beginning on March 1, 2012 and for the remainder of the Term, the Company will pay Consultant an hourly fee of $300 per hour (exclusive of travel time to/from the
Company’s headquarters in Mountain View, CA) for work requested in advance in writing by the CEO, payable in arrears 30 days after receipt of an invoice detailing hours (which shall be provided to the Company within 30 days following the end of
each month). 

  

	5.	Expenses, including Consultant’s time, for pre-approved travel will be reimbursed by the Company in accordance with the Company’s then-current expense
reimbursement policy. 

  

	6.	“Services” means work conducted by Consultant at the direct request of the Company’s CEO, principally (i) as a technology and clinical resource, and
(ii) with regard to physician interactions. Consultant shall make himself available to provide up to 32 hours of Services per month during the Term. The Company shall provide reasonable advance notice of the Services to be requested to
accommodate Consultant’s schedule. 

  
 6Amendment to Purchase Agreement

 Exhibit 10.84 
 AMENDMENT TO 
 PURCHASE AGREEMENT 

THIS AMENDMENT (the “Amendment”) is by and between Hansen Medical, Inc. (“Buyer” or “Hansen”) and Plexus Corp., pka Plexus
Services Corp. (“Seller” or “Plexus”) and amends the Purchase Agreement, Agreement No. SS02AUG2007, effective September 21, 2007, and as amended from time to time between the parties (the “Agreement”). 

WITNESSETH: 

WHEREAS, the parties desire to amend the Agreement as set forth below. 
 NOW THEREFORE, in consideration of the mutual agreements contained herein and other good and valuable consideration, the receipt of which is hereby acknowledged, the parties agree to amend the
Agreement as follows: 
  

	 	1.	Amend Introductory Section by updating the parties name(s) and/or addresses so that it reads as follows: 

Plexus Corp. 
 One Plexus Way 
 Neenah, WI 54956 

Hereinafter referred to as “Seller” or “Plexus” 

and 
 Hansen Medical, Inc. 
 800 East Middlefield Road 

Mountain View, CA 94043 
 Hereinafter referred to as “Buyer” or “Hansen” 
  

	 	2.	Amend Section 1 by replacing the first sentence so that it reads as follows: “This Agreement shall commence and be effective as of September 21, 2007 and
shall remain in effect until May 31, 2016, unless terminated sooner under the provisions set forth herein.” 

  

	 	3.	Amend Section 5.5 by replacing the first sentence so that it reads as follows: “Payment terms shall be net [***] from the date of receipt of invoice of such
Product with a discount of [***].” 

  

	 	4.	Amend Section 5 by adding the following new subsection 5.7: 

  

	 	5.7	 The parties acknowledge that a certain level of business is required to cover Seller’s fixed costs during the manufacturing process, and in the
event that certain levels of business fall below those requirements, that Buyer agrees to compensate Seller for those fixed costs based on the matrix below. Within ten (10) days after the beginning of each calendar quarter, Seller shall
provided Buyer with a (a) summary of Seller’s Quarterly Production Revenue (as defined below) from manufacturing Products in the prior calendar quarter, and (b) fixed cost recovery amount for the previous calendar quarter based on the
fixed costs in the matrix below. Buyer shall issue a purchase order for the fixed cost recovery amount no later than the twentieth (20th) day of the first month of each calendar quarter, and Seller shall invoice Buyer accordingly. This process shall
occur every calendar quarter in which the Quarterly Production Revenue is less than [***]. For purposes of this section, Quarterly Production Revenue includes revenue from manufacturing printed circuit board assemblies, higher level assemblies and
prototype assemblies, but does not include revenue from component/material sales or non-reoccurring engineering sales. 

  

					
	 Quarterly Production Revenue
	  	Fixed Cost Recovery	 
	 [***]
	  	 	[***	] 

  

	 	5.	Amend Section 6.2 by replacing the first sentence so that it reads as follows: “Title and risk of loss of Products ordered by Buyer hereunder shall pass to
Buyer, FCA (Seller’s facility) Incoterms 2010.” 

 [***] CONFIDENTIAL PORTIONS OF THIS DOCUMENT
REDACTED AND SEPARATELY FILED WITH THE COMMISSION 

  
 1 

	 	6.	Amend Section 7.6.2 by replacing the introductory paragraph and subsections a) and b) with the following (for purposes of clarity, subsections c), d) and e) remain
intact): 

  

	 	7.6.2	Excess Components: “Excess Components” shall be defined as 100% of the on-hand components held by Seller in its inventory for more than [***]. Buyer’s
liability for Excess Components shall be handled with the following process: 

  

	 	a)	Seller shall generate a report and provide it to Buyer by the end of the first week of the second month of each calendar quarter. Buyer and Seller shall review and
agree on as to the report’s accuracy and the dollar value of the then-current Excess Components, which shall be based upon Seller’s then-current standard component cost use in the most recent Product quotation. No later than the end of the
second month of each calendar quarter, Buyer shall issue a purchase order for the agreed upon dollar value, and Seller shall invoice Buyer accordingly. Buyer shall submit a cash deposit in the amount of such invoice no later than the last day of the
third month of the calendar quarter. The process shall repeat each calendar quarter. If the Excess Component value increases from the previous calendar quarter, Buyer shall make an additional deposit to cover the increase. Similarly, if the Excess
Component value decreases from the previous calendar quarter, Seller shall return by the end of the third month of the calendar quarter the appropriate portion of the deposit to bring the deposit in line with the Excess Component value.

  

	 	b)	The cash deposits are paid as security against Buyer’s liability to Seller, and its affiliates under any contract between them including, but not limited to,
liability for services, manufactured finished goods, work-in-process and Excess Components and/or Obsolete Components purchased in support of Buyer’s requests. Seller shall hold this sum as a deposit against such liabilities, with Seller
having the right to apply the amount held in deposit against any such liabilities at any time upon [***] advance written notice only if Buyer: (i) becomes insolvent, (ii) files, or has filed against it, a petition in bankruptcy,
(iii) makes an assignment for the benefit of creditors, or (iv) generally becomes unable to pay its debts as they become due. Seller shall provide Buyer with an accounting of amounts held on deposit, and payments made out of deposit,
at any time upon reasonable request. Upon written request from Buyer at any time, Seller shall return to Buyer amounts held on deposit following satisfaction of any and all outstanding obligations or potential liabilities of Buyer to Seller;
provided, return of such deposit shall provide Seller with the right and opportunity to perform an updated credit analysis prior to the acceptance of future orders. 

 

	 	7.	Amend Section 8.3 by correcting a typographical error, wherein the last word of the second sentence incorrectly references “Seller” as opposed to
correctly referencing “Buyer.” The last word of the second sentence is changed from “Seller” to “Buyer” so the sentence reads as follows: “Seller may terminate for its convenience and without cause this Agreement
and/or any purchase orders issued against this Agreement at any time in whole or part by delivering [***] written notice of termination to Buyer.” 

  

	 	8.	All other terms and conditions of the Agreement, not inconsistent herewith, shall remain in full force and effect. 

IN WITNESS WHEREOF, the parties have caused their duly authorized officers to execute this Agreement as of the date(s) indicated below.

  

									
	Plexus Corp.	 		 	Hansen Medical, Inc.
					
	By:	 	 /s/ Todd Kelsey
	 		 	By:	 	 /s/ Bruce Barley

	Name:	 	Todd Kelsey	 		 	Name:	 	 Bruce Barley

		 	Executive Vice President-Global Customer Services	 		 	Title:	 	 President and CEO

	Date:	 	 9/20/2011
	 		 	Date:	 	 9/29/2011

 [***] CONFIDENTIAL PORTIONS OF THIS DOCUMENT REDACTED AND SEPARATELY FILED WITH THE COMMISSION

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]